A new classification for hepatocellular carcinoma with portal vein tumor thrombus

医学 肝细胞癌 门静脉 肝切除术 阶段(地层学) 回顾性队列研究 放射科 生存分析 血栓 存活率 胃肠病学 内科学 外科 切除术 古生物学 生物
作者
Jie Shi,Eric C. H. Lai,Nan Li,Wei‐Xing Guo,Jie Xue,Wan‐Yee Lau,Mengchao Wu,Shuqun Cheng
出处
期刊:Journal of Hepato-biliary-pancreatic Sciences [Wiley]
卷期号:18 (1): 74-80 被引量:185
标识
DOI:10.1007/s00534-010-0314-0
摘要

Abstract Background/purpose We aimed to correlate the survival of patients with hepatocellular carcinoma (HCC) with macroscopic portal vein tumor thrombus (PVTT) who underwent partial hepatectomy with or without portal thrombectomy with our PVTT classification. Currently, different staging systems for HCC are widely used in clinical practice. However, they lack the refinement in giving prognosis and guiding surgical treatment once macroscopic PVTT is present. Methods A retrospective study was carried out, in a single tertiary center, from January 2001 to December 2004 on 441 patients who underwent partial hepatectomy with or without portal thrombectomy for HCC with macroscopic PVTT. Overall survival was examined to determine whether it was correlated with our PVTT classification, and with the TNM staging, Cancer of the Liver Italian Program (CLIP) scoring system, and the Japan Integrated Staging (JIS) scoring system. Results With our PVTT classification, the numbers (percentages) of patients with types I, II, III, and IV PVTT were 144 (32.7%), 189 (42.9%), 86 (19.5%), and 22 (5.0%), respectively. The corresponding 1‐, 2‐, and 3‐year overall survival rates for types I to IV PVTT were 54.8, 33.9, and 26.7%; 36.4, 24.9, and 16.9%; 25.9, 12.9, and 3.7%; and 11.1, 0, and 0%, respectively (log‐rank of the survival curves p < 0.0001). Using the TNM system, the majority of patients were classified as stage III ( n = 379 or 85.9%). Similarly, the majority of patients ( n = 388 or 88.0%) were classified as having CLIP scores of 2 ( n = 143, or 32.4%), 3 ( n = 171, or 38.8%), and 4 ( n = 74, or 16.8%). The 1‐, 2‐, and 3‐year overall survivals for these 3 CLIP scores were very similar. Using the JIS score, the majority of patients ( n = 372 or 84.4%) were classified with a JIS score of 2. The 1‐, 2‐, and 3‐year overall survivals of patients with a JIS score of 2 were worse than those of the patients with a JIS score of 1 (this was expected) as well as being worse than those with a JIS score of 3 (this was unexpected). Thus, the latter 3 systems of classification were not refined enough, and they were inadequate for stratifying HCC with macroscopic PVTT treated with partial hepatectomy with or without thrombectomy. Conclusions In patients with HCC with macroscopic PVTT treated by partial hepatectomy with or without thrombectomy, our PVTT classification better stratified and predicted prognosis than the TNM staging, CLIP scoring system, and JIS scoring system, which were unrefined and inadequate for this group of patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
yuanyuan完成签到,获得积分10
1秒前
1秒前
2秒前
jingran127完成签到 ,获得积分10
2秒前
互助应助魏笑白采纳,获得30
2秒前
超帅飞机发布了新的文献求助30
3秒前
量子星尘发布了新的文献求助10
3秒前
3秒前
积极向上完成签到,获得积分10
3秒前
Jasper应助chimchim采纳,获得10
3秒前
吱吱吱吱发布了新的文献求助10
3秒前
充电宝应助YYT采纳,获得10
4秒前
脑洞疼应助高群采纳,获得10
4秒前
5秒前
上官若男应助keyan_xiaojiang采纳,获得10
5秒前
6秒前
6秒前
Kiefer完成签到 ,获得积分10
7秒前
不安宝川发布了新的文献求助10
7秒前
小何发布了新的文献求助10
7秒前
Hello应助下雨这天采纳,获得10
7秒前
99完成签到,获得积分10
7秒前
7秒前
大模型应助潇洒夜安采纳,获得10
7秒前
8秒前
Zhang发布了新的文献求助10
8秒前
搜集达人应助叶祥采纳,获得10
8秒前
9秒前
10秒前
10秒前
10秒前
hoijuon应助海宁采纳,获得10
11秒前
11秒前
研友_ZrBNxZ完成签到,获得积分10
11秒前
吴小利完成签到,获得积分10
12秒前
123完成签到,获得积分10
12秒前
不想起完成签到,获得积分10
12秒前
12秒前
星辉的斑斓完成签到 ,获得积分10
12秒前
Kenny完成签到,获得积分10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 3000
Signals, Systems, and Signal Processing 610
Discrete-Time Signals and Systems 610
Research Methods for Business: A Skill Building Approach, 9th Edition 500
Social Work and Social Welfare: An Invitation(7th Edition) 410
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6053590
求助须知:如何正确求助?哪些是违规求助? 7873617
关于积分的说明 16278909
捐赠科研通 5198946
什么是DOI,文献DOI怎么找? 2781701
邀请新用户注册赠送积分活动 1764628
关于科研通互助平台的介绍 1646217